The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sinha Uma since 2019.
This trader's CIK number is 1742587.
At the time of last reporting, Sinha Uma was the Chief Scientific Officer of Eidos Therapeutics, Inc.. (stock ticker symbol EIDX).
Also see all insider trading activities at Eidos Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | EIDX | 0 | $0 | 10,000 | $1,238,860 | 0 | $0 |
| 2020 | EIDX | 0 | $0 | 15,000 | $1,079,371 | 0 | $0 |
| 2019 | EIDX | 0 | $0 | 25,000 | $1,200,197 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | BBIO | 0 | $0 | 0 | $0 | 937 | $0 |
| 2019 | BBIO | 14,000 | $238,000 | 0 | $0 | 0 | $0 |
1. Eidos Therapeutics, Inc. (EIDX)
2. Bridgebio Pharma, Inc. (BBIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-13 | EIDX | Sale | 10,000 | 123.89 | 1,238,860 |
| 2020-12-02 | EIDX | Sale | 5,000 | 91.28 | 456,395 |
| 2020-10-29 | EIDX | Sale | 5,000 | 72.25 | 361,260 |
| 2020-10-01 | EIDX | Sale | 4,831 | 52.35 | 252,922 |
| 2020-09-30 | EIDX | Sale | 169 | 52.04 | 8,794 |
| 2019-12-18 | EIDX | Sale | 12,500 | 62.47 | 780,900 |
| 2019-09-25 | EIDX | Sale | 2,500 | 38.76 | 96,907 |
| 2019-07-25 | EIDX | Sale | 5,000 | 36.96 | 184,790 |
| 2019-05-23 | EIDX | Sale | 5,000 | 27.52 | 137,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-16 | BBIO | Option Ex | 469 | .00 | 0 |
| 2020-08-16 | BBIO | Option Ex | 468 | .00 | 0 |
| 2019-07-01 | BBIO | Buy | 14,000 | 17.00 | 238,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sinha Uma (Chief Scientific Officer of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.